Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Why has China achieved remarkable successes in promoting cooperation under Belt and Road Initiative?

Published

on

why-has-china-achieved-remarkable-successes-in-promoting-cooperation-under-belt-and-road-initiative?

BEIJING, Oct. 17, 2023 /PRNewswire/ — A report from People’s Daily: China will host the third Belt and Road Forum for International Cooperation (BRF) in Beijing from Oct. 17 to 18. It is reported that representatives from over 140 countries and more than 30 international organizations have confirmed their attendance at the event.

Despite the turbulent international situation, China has rolled out the red carpet to welcome guests from all over the world, which demonstrates the country’s unswerving commitment to promoting world peace and development.

Over the past decade since Chinese President Xi Jinping proposed the Belt and Road Initiative (BRI), stories of win-win cooperation have continued to unfold along this public road of shared opportunities and common development.

So far, over 150 countries and more than 30 international organizations have signed more than 200 BRI cooperation agreements with China; the Asian Infrastructure Investment Bank has grown from 57 founding members to 109 members, which account for 81 percent of the world’s population and 65 percent of global GDP; and more than 80 routes have been launched for the ChinaEurope freight trains, reaching 217 cities in 25 European countries.

Experience over the past 10 years has fully proven that the BRI is an open and inclusive platform and a global public good jointly built by all partners.

International analysts have eagerly sought to understand what allowed China to conceive the grand initiative and accomplish significant achievements in furthering its development.

The BRI is the result of China’s reflections on the future and destiny of humanity. In March 2013, in the face of the profound questions of “What is wrong with the world?” and “What should we do about it?”, which concern the world, history and the times, Xi creatively proposed the concept of building a global community with a shared future for mankind.

By launching the BRI, China aims to put this concept into practice and build a practical platform and open up paths for creating an open, inclusive, clean and beautiful world that enjoys lasting peace, universal security and common prosperity.

The BRI stemmed from China’s unshakeable pursuit of world peace and development. China unswervingly follows the path of peaceful development. It safeguards world peace to ensure its own growth, and contributes to world peace through its own development.

Taking the path of peaceful development is China’s response to international concerns about its development direction, and also a reflection of the confidence and consciousness of the Chinese people in achieving their development goals.

By proposing the BRI, China strives not only to pursue its own development and enhance its capacity to safeguard world peace, but also to benefit the world by strengthening the forces for upholding world peace and development.

In pursuing Belt and Road cooperation, China will not resort to the outdated geopolitical maneuvering, but will create a new model of win-win cooperation. It will not form “a small group detrimental to stability”, but will try to create “a big family of harmonious coexistence”.

The success of the BRI represents the success of China’s development path and experience. China has achieved the two miracles of rapid economic growth and long-term social stability, resolved its problem of absolute poverty once for all, and realized its first centenary goal of building a moderately prosperous society in all respects. The fundamental reason for these achievements is that China has found a successful development path that is suited to its national conditions and people’s aspirations and supported by its people.

With nine percent of the world’s arable land and six percent of the freshwater resources, China feeds nearly one-fifth of the world’s population. In 2022, China’s GDP expanded to 121 trillion yuan ($16.56 trillion), while its share of the global economy rose to 18 percent, demonstrating remarkable development achievements.

The success of China’s development path has strengthened other developing countries’ determination to pursue paths based on their own national realities, and China’s great achievements in development have boosted other developing countries’ confidence in realizing national prosperity, national rejuvenation and improving people’s wellbeing. The BRI has provided valuable opportunities for other developing countries to draw on China’s development experience.

The success of the BRI is the success of China’s commitment to open development. Only when a country is strong enough can it have the confidence to open its doors to the world, and opening up in turn enhances its prosperity. The BRI is a major initiative China has launched to expand opening up. It is not a solo endeavor by China, but a collaborative effort involving all stakeholders.

In the face of a rising tide of de-globalization, China remains firmly committed to high-level opening up, creating an even brighter future for cooperation under the BRI.

The BRI has continuously broken deadlocks, removed bottlenecks and spurred innovations, showing the world that only by building an open world economy can countries improve the wellbeing of their peoples.

As former Spanish Prime Minister Jose Luis Rodriguez Zapatero pointed out, the BRI upholds an open and inclusive vision for development that transcends borders and zero-sum game mindset, which is precisely the development philosophy the world urgently needs today.

Photo – https://mma.prnewswire.com/media/2249038/image.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/why-has-china-achieved-remarkable-successes-in-promoting-cooperation-under-belt-and-road-initiative-301958199.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending